Warfarin Dosage Response Related Pharmacogenetics in Chinese Population - Concepedia

Concepedia

Publication | Open Access

Warfarin Dosage Response Related Pharmacogenetics in Chinese Population

DOI Full Paper Access

38

Citations

27

References

2015

Year

Siyue Li, Yuangao Zou, Xia Wang, Xunbei Huang, Yong Sun, Yuqing Wang, Li Dong, Hong Jiang

Abstract

A better understanding of the genetic variants in individuals can be the foundation of warfarin dosing algorithm and facilitate the reasonable and effective use of warfarin in Chinese.

References

	Year	Citations
The Pharmacology and Management of the Vitamin K Antagonists Jack Ansell, Jack Hirsh, L. Poller, CHEST Journal Vitamin K AntagonistsPharmacological StudyMedicineClinical PharmacologyPharmacotherapy	2004	1.5K
Heparin and Low-Molecular-Weight Heparin Jack Hirsh, Robert Raschke CHEST Journal ThrombopoiesisBiochemistryBlood PlateletHemostasisHeparins	2004	953
The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen Elizabeth Sconce, Tayyaba Khan, Hilary Wynne, Blood	2005	945
A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin Giovanna D’Andrea, Rosa D’Ambrosio, P Perna, Blood	2004	695
CYP4F2 genetic variant alters required warfarin dose Michael D. Caldwell, Tarif Awad, Julie A. Johnson, Blood	2008	519
The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Jack Hirsh, Gordon Guyatt, Gregory W. Albers, CHEST Journal ThrombosisMedicineHematologySeventh Accp ConferencePharmacotherapy	2004	410
Association of warfarin dose with genes involved in its action and metabolism Mia Wadelius, Leslie Y. Chen, Niclas Eriksson, Human Genetics	2006	397
Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups Nita A. Limdi, Mia Wadelius, Larisa H. Cavallari, Blood	2010	370
Cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genotypes as determinants of acenocoumarol sensitivity Laurent Bodin Blood	2005	357
CYP4F2 Is a Vitamin K1 Oxidase: An Explanation for Altered Warfarin Dose in Carriers of the V433M Variant Matthew G. McDonald, Mark J. Rieder, Mariko Nakano, Molecular Pharmacology	2009	319

Page 1